Henrik Schimmell – President, Radiometer
Henrik Schimmell outlines the critical importance of blood gas testing – a field in which Radiometer has long been a pioneer – and how the company’s portfolio of diagnostic tools…
Address:
LEO Pharma A/S
Industriparken 55 DK-2750
Ballerup
Danmark
Tel: +45 4494 5888
Fax: +45 7226 3321
Web: http://www.leo-pharma.com/
Leo Pharma is an independent, research-based pharmaceutical company. The company develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise their vision of becoming the preferred dermatology care partner improving people’s lives around the world, they are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs. Leo Pharma has its own sales forces in 61 countries and employs around 5,000 employees worldwide. The company is headquartered in Denmark and is wholly owned by the Leo Foundation.
Dermatological products
Henrik Schimmell outlines the critical importance of blood gas testing – a field in which Radiometer has long been a pioneer – and how the company’s portfolio of diagnostic tools…
In a wide-ranging and candid conversation, Siemens Healthineers’ Tisha Boatman discusses uprooting from the US to Denmark, how Danish hospital tendering needs to evolve beyond price considerations alone, the challenges…
Kenneth Mikkelsen & Jeroen ter Borg describe the work of IQVIA – the world’s biggest CRO and life science data services provider – in Denmark, which has served as a…
Servier’s Estève Speranza outlines the rationale behind the French group’s reorganisation in the Nordic countries, how the global shift towards oncology is playing out in his region, and the Nordics’…
Speaking after the recent completion of a three-year strategic transformation plan, ALK President and CEO Carsten Hellmann outlines the progress made by the Danish allergy giant under his stewardship, including…
The BioInnovation Institute (BII) is an initiative from the Novo Nordisk Foundation which aims to support entrepreneurial researchers and early-stage life science start-ups with up to DKK 18 million in…
Lisbeth Nielsen of the Danish Health Data Authority outlines the organisation’s purpose and mission, how it contributed to Denmark’s robust COVID-19 response, and the challenges of making Denmark’s comprehensive patient…
Alphalyse is a Danish contract research organization (CRO) specialising in protein chemistry, mass spectrometry, and bioinformatics. The firm’s co-founder & COO Ejvind Mørtz outlines its journey since its foundation in…
Kasper Bødker Mejlvang oversees Novo Nordisk’s operations in its historic home market of Denmark, as well as Iceland. Here, Bødker Mejlvang explains his strategy for steering the Danish affiliate through…
Newly appointed Director of Invest in Denmark Anne Hougaard Jensen outlines her initial priority list, how the agency is dialling in on the areas in which Denmark has a particular…
Zealand Pharma’s Emmanuel Dulac, fresh from a first US FDA approval for the company’s rescue pen for severe hypoglycaemia in people with diabetes aged 6 years and older, outlines the…
Dr Tina Hahn explains how AXON positions itself as a strategic partner for its Danish clients in their scientific communication work, highlights how the COVID-19 pandemic has foregrounded the importance…
See our Cookie Privacy Policy Here
